α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 20 setembro 2024

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery - ScienceDirect

Pharmacogenetics of the human beta-adrenergic receptors

IJTM, Free Full-Text

Influence of pH on the uptake and toxicity of β-blockers in embryos of zebrafish, Danio rerio - ScienceDirect

What Is the Role of β-Adrenergic Signaling in Heart Failure?

Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure - Journal of Molecular and Cellular Cardiology

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

Structures of β1-adrenergic receptor in complex with Gs and ligands of different efficacies

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

NATIONAL GUIDELINES ON QUALITY OBSTETRICS AND PERINATAL CARE Final Feb 2022 PDF, PDF, Malnutrition

Updates in the function and regulation of α1‐adrenoceptors - Akinaga - 2019 - British Journal of Pharmacology - Wiley Online Library

Adrenergic receptor autoantibodies - Wikipedia

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol - an overview

Recomendado para você